Capecitabine
Showing 1 - 25 of 2,332
Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)
Not yet recruiting
- Breast Cancer
- Mitoxantrone hydrochloride liposome
- Capecitabine
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023
Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)
Not yet recruiting
- Pancreas Cancer
- Pancreas Adenocarcinoma
- Capecitabine
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
Oct 29, 2023
to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally
Recruiting
- to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
- Capecitabine 500Mg Oral Tablet
-
Shanghai, ChinaEye & ENT Hospital, Fudan University
Jul 2, 2023
Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Residual Disease
- Tetrathiomolybdate
- +2 more
- (no location specified)
Nov 15, 2023
Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)
Not yet recruiting
- Gastrointestinal Cancer
- Capecitabine
- Sacituzumab govetican
- (no location specified)
Oct 2, 2023
Recurrent Metastatic Nasopharyngeal Carcinoma Trial (Mitoxantrone HCl liposome injection, Capecitabine)
Not yet recruiting
- Recurrent Metastatic Nasopharyngeal Carcinoma
- Mitoxantrone hydrochloride liposome injection
- Capecitabine
- (no location specified)
Jan 29, 2023
Recurrent or Metastatic Colorectal Cancer Trial (Nelmastobart and Capecitabine)
Not yet recruiting
- Recurrent or Metastatic Colorectal Cancer
- Nelmastobart and Capecitabine
- (no location specified)
Aug 6, 2023
Metastatic Breast Cancer Trial in Birmingham (Capecitabine Pill)
Not yet recruiting
- Metastatic Breast Cancer
- Capecitabine Pill
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Oct 23, 2023
Colorectal Carcinoma Trial (Fruquintinib?Capecitabine Tablets)
Not yet recruiting
- Colorectal Carcinoma
- FruquintinibćCapecitabine Tablets
- (no location specified)
Oct 30, 2023
Breast Cancer Stage I Trial (Capecitabine,Pyrotinib)
Not yet recruiting
- Breast Cancer Stage I
- (no location specified)
May 7, 2023
Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib alternating with Bevacizumab plus Capecitabine, Bevacizumab plus
Recruiting
- Metastatic Colorectal Cancer
- Fruquintinib alternating with Bevacizumab plus Capecitabine
- Bevacizumab plus Capecitabine
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Jan 4, 2023
Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)
Recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- Capecitabine
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023
Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Carrilizumab, bevacizumab,capecitabine
- (no location specified)
Jul 20, 2023
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2
Recruiting
- HER2-positive Breast Cancer
- Early-stage Breast Cancer
- pyrotinib combined with Capecitabine
- treatment of physician's choice
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 6, 2023
Advanced Gastric Carcinoma Trial in Dhaka (Trastuzumab, Oxaliplatin, Capecitabine)
Completed
- Advanced Gastric Carcinoma
- Trastuzumab
- +2 more
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Aug 15, 2023
Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)
Not yet recruiting
- Triple Negative Breast Neoplasms
- Pembrolizumab injection
- +2 more
- (no location specified)
Jul 25, 2023
Breast Cancer Trial in Xi'an (Inetetamab plus pyrotiniband and capecitabine)
Active, not recruiting
- Breast Cancer
- Inetetamab plus pyrotiniband and capecitabine
-
Xi'an, Shaanxi, ChinaXi'an International Medical Center Hospital
Aug 27, 2023
Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)
Recruiting
- Breast Cancer With Brain Metastases
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 22, 2023
Breast Cancer Trial (SHR-A1811 for injection ; capecitabine)
Not yet recruiting
- Breast Cancer
- SHR-A1811 for injection ; capecitabine
- (no location specified)
May 4, 2023
Breast Cancer Trial in Beijing (oral vinorelbine and capecitabine)
Recruiting
- Breast Cancer
- oral vinorelbine and capecitabine
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Feb 27, 2023
Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)
Recruiting
- Gastric Cancer, Adjuvant Chemotherapy, XO
- Docetaxel and capecitabine and oxaliplatin
- capecitabine and oxaliplatin
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Nasopharyngeal Tumors Trial (The combination treatment of anlotinib, penpulimab and capecitabine.)
Not yet recruiting
- Nasopharyngeal Neoplasms
- The combination treatment of anlotinib, penpulimab and capecitabine.
- (no location specified)
Apr 10, 2023
Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)
Not yet recruiting
- Nasopharyngeal Carcinoma
- CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
-
Singapore, Singapore
- +1 more
Oct 16, 2023
HER2 Positive Metastatic Breast Cancer Trial in Beijing (pyrotinib, , Capecitabine)
Active, not recruiting
- HER2 Positive Metastatic Breast Cancer
- pyrotinib
- +2 more
-
Beijing, China307 Hospital Affiliated to Academy Military Medical Science
Oct 24, 2022
Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)
Recruiting
- Unresectable/Metastatic Colorectal Cancer
- Fruquintinib plus camrelizumab and capecitabine
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 19, 2023